GlassScriptPhysician profile
Nathaniel R Toop
NPI 1518487743
$55,747.54
in general payments reported to CMS, 2019-2025
11 companies · $2,362 in 2025
The $2,362 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.24 · 2023: $182 · 2024: $53K · 2025: $2,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $2,896 · Travel and Lodging: $2,783 · Education: $53.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $2,895.73 |
| Travel and Lodging | $2,783.42 |
| Education | $53.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $51,858.91 | 2024-2025 | Cd Horizon Spinal System, Stealthstation S8 Platform, Mazor X System |
| Globus Medical, INC. | $3,069.51 | 2024-2025 | Quartex, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Si-Bone, INC. | $180.81 | 2024-2025 | |
| Icotec Medical INC. | $137.08 | 2023 | Icotec Blackarmor Spine System |
| Sanara Medtech INC. | $114.24 | 2025 | Celleraterx |
| Depuy Synthes Sales INC. | $112.33 | 2025 | Expedium Verse |
| Bioventus LLC | $108.47 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Cerapedics INC. | $53.15 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Intrinsic Therapeutics | $52.99 | 2025 | Barricaid Acd (Annular Closure Device) |
| Nuvasive, INC. | $44.81 | 2023 | Modulus, Xlif |
| Irras USA, INC. | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Toop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.